Please login to the form below

Not currently logged in
Email:
Password:

giant cell tumour of the bone

This page shows the latest giant cell tumour of the bone news and features for those working in and with pharma, biotech and healthcare.

FDA clears Amgen's Xgeva for rare bone condition

FDA clears Amgen's Xgeva for rare bone condition

US approval provides alternative to surgery for use in giant cell tumour of the bone.  . ... The US FDA yesterday gave a green to the use of Amgen's Xgeva (denosumab) to treat adults and some adolescents with giant cell tumour of the bone (GCTB).

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics